Cheryl R. Blanchard - 09 Mar 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: President, CEO, Director, Director
Signature: /s/ Cheryl R. Blanchard
Issuer symbol: ANIK
Transactions as of: 09 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 11 Mar 2022, 16:35:28 UTC
Previous filing: 03 Mar 2022
Next filing: 14 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+14,420	+38%	$0.000000	51,892	09 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-14,420	-33%	$0.000000	28,839	09 Mar 2022	Common Stock	14,420	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. The 14,420 shares resulting from the RSU vest were retained in full as a result of Dr. Blanchard's election to pay cash to cover the applicable taxes resulting from the RSU vest.
F2	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.